United Therapeutics lands FDA approval linked to drug at center of patent lawsuits

United Therapeutics Corporation (Nasdaq: UTHR) – which is headquartered in Silver Spring, Maryland, and has an office in Research Triangle Park – has landed U.S. Food and Drug Administration approval for a new device to be used with one of its drugs currently at the center of a number of patent-related lawsuits.  The company received FDA a pproval for its pulmonary hypertension drug Tyvaso back in 2009, and its latest approval is for a new inhalation device – called TD-300/A – to be used…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news